BioSpace News Archive

Pharm Country

Journal for ImmunoTherapy of Cancer Highlights New Single Cell Bioinformatics Tools From IsoPlexis Used To Characterize Differences in CAR-T Products

These new tools enable researchers to better compare key differences between products, and more easily analyze highly-multiplexed, single CAR-T cell functional profiles to gain insight into CAR-T product potency and cytokine mediated immuno-toxicity.

November 21, 2017

·

3 min read

MiMedx Provides Update on its Reimbursement Coverage

MiMedx provided a reimbursement update today.

November 21, 2017

·

6 min read

Business

Lead Pharma Achieves Third Milestone in Sanofi Collaboration for Development of Autoimmune Diseases Treatments

The collaboration aims to develop small molecules directed against the nuclear hormone receptor ROR gamma (t) for the treatment of a broad range of autoimmune disorders, including common diseases such as psoriasis, rheumatoid arthritis and inflammatory bowel disease.

November 21, 2017

·

1 min read

Pharm Country

New Stax mAx Clarification Platform From Pall Life Sciences Delivers Robust, Accelerated Performance Across Multiple mAb Processes

The single-use harvesting platform features a 4-layer concept, and has been optimized to maintain performance as cell density and viability change to minimize the impact of process variability between batches.

November 21, 2017

·

2 min read

Biotech Bay

Glassbeam Announces Healthcare Industry’s First Industrial IoT Analytics Blueprint

The blueprint is already in production at leading sites such as Novant Health analyzing machine logs and providing proactive and predictive analytics.

November 21, 2017

·

5 min read

Drug Development

Aclaris Therapeutics Presents New Data at American College of Rheumatology Annual Meeting For ATI-450, a MK2 pathway Inhibitor

Dr. Gabriel Mbalaviele presented data from pre-clinical studies of Aclaris’ recently acquired drug candidate, ATI-450.

November 21, 2017

·

3 min read

Genetown

Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference

A live webcast of the presentation will be available online from the investor relations page of the Company’s corporate website at www.oxfordimmunotec.com.

November 21, 2017

·

1 min read

Business

Immunovaccine and Leidos Expand Collaboration to Develop Malaria Vaccines Formulated in DepoVax

The two companies will expands its collaboration to develop preventative, peptide-based malaria vaccine candidates.

November 21, 2017

·

5 min read

Business

Promore Pharma Release: Interim Report January - September 2017

Overall, the company’s main activities during the third quarter have been focused on continued planning of our clinical commitments.

November 21, 2017

·

6 min read

Drug Development

Axim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid Delivery Method for Treatment of Irritable Bowel Syndrome (IBS)

Participants of AXIM Biotech’s Phase IIa trial experienced a decrease in their pain score and improvement in their quality of life score, highlighting the efficacy of AXIM’s patented CBD chewing gum delivery method, allowing for AXIM to move forward with further trials with predetermined dosing.

November 21, 2017

·

4 min read